The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres S Simoens, G Dunselman, C Dirksen, L Hummelshoj, A Bokor, I Brandes, ... Human reproduction 27 (5), 1292-1299, 2012 | 1125 | 2012 |
The significant effect of endometriosis on physical, mental and socialwellbeing: results from an international cross-sectional survey SS A.A. De Graaff, T.M. D’Hooghe, G.A.J. Dunselman1 Human Reproduction,, pp. 1–9, 2013, 2013 | 507* | 2013 |
Cost‐effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C C Camma, S Petta, M Enea, R Bruno, F Bronte, V Capursi, A Cicchetti, ... Hepatology 56 (3), 850-860, 2012 | 147 | 2012 |
Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years S Esposito, P Marchisio, S Bosis, L Lambertini, L Claut, N Faelli, ... Vaccine 24 (5), 629-635, 2006 | 115 | 2006 |
Shadow cost of oral corticosteroids-related adverse events: a pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry GW Canonica, GL Colombo, GM Bruno, S Di Matteo, C Martinotti, F Blasi, ... World Allergy Organization Journal 12 (1), 100007, 2019 | 114 | 2019 |
Moderate and severe plaque psoriasis: cost-of-illness study in Italy GL Colombo, GF Altomare, K Peris, P Martini, G Quarta, M Congedo, ... Therapeutics and clinical risk management 4 (2), 559-568, 2008 | 108 | 2008 |
The economic burden of hyponatremia: systematic review and meta-analysis G Corona, C Giuliani, G Parenti, GL Colombo, A Sforza, M Maggi, G Forti, ... The American journal of medicine 129 (8), 823-835. e4, 2016 | 102 | 2016 |
Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries S Evers, A Ament, GL Colombo, HB Konradsen, RR Reinert, D Sauerland, ... European Journal of Clinical Microbiology & Infectious Diseases 26, 531-540, 2007 | 94 | 2007 |
Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors PA Cortesi, G Castaman, G Trifirò, SS Creazzola, G Improta, G Mazzaglia, ... Thrombosis and Haemostasis 120 (02), 216-228, 2020 | 67 | 2020 |
Cost–benefit of reflectance confocal microscopy in the diagnostic performance of melanoma G Pellacani, A Witkowski, AM Cesinaro, A Losi, GL Colombo, ... Journal of the European Academy of Dermatology and Venereology 30 (3), 413-419, 2016 | 67 | 2016 |
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors GL Colombo, SD Matteo, LM Mir Therapeutics and Clinical Risk Management 4 (2), 541-548, 2008 | 64 | 2008 |
Cost-effectiveness of adjuvanted influenza vaccination of healthy children 6 to 60 months of age M Marchetti, UM Kühnel, GL Colombo, S Esposito, N Principi Human Vaccines 3 (1), 14-22, 2007 | 62 | 2007 |
Economic and outcomes consequences of TachoSil®: a systematic review GL Colombo, D Bettoni, S Di Matteo, C Grumi, C Molon, D Spinelli, ... Vascular health and risk management, 569-576, 2014 | 58 | 2014 |
Cost-benefit analysis of influenza vaccination in a public healthcare unit GL Colombo, A Ferro, M Vinci, M Zordan, G Serra Therapeutics and clinical risk management 2 (2), 219-226, 2006 | 58 | 2006 |
Adherence in ulcerative colitis: an overview A Testa, F Castiglione, OM Nardone, GL Colombo Patient preference and adherence, 297-303, 2017 | 55 | 2017 |
Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health … M Marchetti, M Caruggi, G Colombo Clinical therapeutics 26 (9), 1546-1561, 2004 | 46 | 2004 |
Proposta di linee guida per la valutazione economica degli interventi sanitari G Aguzzi, G Baio, S Capri, M Cavazza, A Cicchetti, C Cislaghi, ... Politiche sanitarie 10 (2), 83-93, 2009 | 44 | 2009 |
Cost–utility analysis of prophylaxis versus treatment on demand in severe hemophilia A GL Colombo, S Di Matteo, ME Mancuso, E Santagostino Clinicoeconomics and outcomes Research, 55-61, 2011 | 43 | 2011 |
Cost-effectiveness of universal pneumococcal vaccination for infants in Italy M Marchetti, GL Colombo Vaccine 23 (37), 4565-4576, 2005 | 43 | 2005 |
A one health framework to estimate the cost of antimicrobial resistance CM Morel, RA Alm, C Årdal, A Bandera, GM Bruno, E Carrara, ... Antimicrobial Resistance & Infection Control 9, 1-14, 2020 | 42 | 2020 |